West Bengal Chemical Industries Limited bagged 9 Patents in API Manufacturing

Kolkata, India - West Bengal Chemical Industries Limited (WBCIL), a name synonymous with innovation and excellence in Active Pharmaceutical Ingredient (API) manufacturing, proudly announces the achievement of nine revolutionary patents. This landmark achievement is a testament to our relentless pursuit of solutions that address global healthcare challenges and elevate the standards of pharmaceutical science.

Since our inception in 1962, WBCIL has been at the forefront of pharmaceutical innovation, earning recognition as one of India's top API manufacturers. Over six decades, we have evolved into a global leader with a strong portfolio of products designed to improve health outcomes and meet the diverse needs of our partners and clients worldwide.

Redefining API Manufacturing: The Power of Nine Patents

Our nine patents exemplify WBCIL's dedication to driving technological advancements and fostering sustainable development in the pharmaceutical sector. These include:

Ferric Carboxymaltose: A widely-used intravenous treatment for iron deficiency, optimized for efficiency and safety with negligible anaphylactic shock.
Product link: https://www.wbcil.com/api-fine-chemicals-nutraceutical/iron/ferric-carboxymaltose/

Iron Isomaltoside: An innovative injectable API designed for improved tolerability and efficacy for fast increase in iron level.
Product link: https://www.wbcil.com/api-fine-chemicals-nutraceutical/iron/iron-isomaltoside/

Iron (III) Coordination Complex: A cutting-edge compound with superior phosphate binding capacity for medical applications.
Product link: https://www.wbcil.com/api-fine-chemicals-nutraceutical/iron/iron-iii-hydroxide-polymaltose/

Ferric Derisomaltose: Engineered for instant iron level increase in case of accidental and huge blood loss with reduced production costs.
Product link: https://www.wbcil.com/api-fine-chemicals-nutraceutical/iron/ferric-derisomaltose/

Ferric Citrate: A solvent-free, environmentally friendly approach to iron supplementation with additional toxin binding property.
Product link: https://www.wbcil.com/api-fine-chemicals-nutraceutical/iron/ferric-citrate/

Sucroferric Oxyhydroxide: A high-performance phosphate binder critical for certain medical treatments.

Enclomiphene Citrate: A cost-effective and advanced process for this essential therapeutic.

Improved Ferric Carboxymaltose: Reducing side effects while ensuring cost-effective scalability.

Ferric Maltol: A novel polymorphic form 'S' of stabilized Ferric Maltol, that can act as oral substitute to injectable iron supplement, setting new benchmarks in API development.

These patents not only represent a significant leap forward in API manufacturing but also highlight WBCIL's role as a catalyst for change in the pharmaceutical industry.

Global Reach and Impact

With operations spanning over 30 countries, including the USA, Europe, the Middle East, and North Africa, WBCIL's products cater to a wide array of industries, from pharmaceuticals to nutraceuticals and animal nutrition. Our diverse portfolio of more than 150 APIs addresses critical global health challenges, making us a trusted partner to over 4,000 clients worldwide.

"Our nine patents are a reflection of our unwavering commitment to innovation, sustainability, and excellence," says Mr. Sunil Kumar Agarwal, Managing Director of WBCIL. "We take immense pride in offering solutions that not only enhance therapeutic outcomes but also ensure accessibility and affordability for patients across the globe."

Innovation Driven by Research and Development

At WBCIL, research and development lie at the core of our success. Our state-of-the-art R&D facilities, equipped with cutting-edge technologies like FT-IR and NMR spectroscopy, empower us to design APIs that are safe, effective, and scalable. Our scientists and engineers work tirelessly to push the boundaries of pharmaceutical science, addressing unmet medical needs and setting new industry standards.

Sustainability at the Heart of Our Vision

We are deeply committed to sustainability, as reflected in our patented processes that minimize environmental impact while maximizing efficiency. From solvent-free production methods to reducing energy consumption in API synthesis, we ensure that innovation and environmental responsibility go hand in hand.

A Vision for the Future

WBCIL is proud to align with India's vision of 'Aatmanirbhar Bharat,' contributing to the nation's self-reliance in pharmaceutical manufacturing. As the global demand for high-quality APIs continues to grow, we are determined to lead the charge in delivering innovative solutions that transform lives and communities.

Looking ahead, we see immense potential in expanding our reach and diversifying our offerings. From advanced drug delivery systems like liposomal APIs to exploring new therapeutic areas, our focus remains on harnessing science and technology to redefine what's possible in healthcare.

Name: West Bengal Chemical Industries Limited
Address: 145/1 Jessore Road, Lake Town, Kolkata - 700089, West Bengal, India
Email: wbcil@wbcil.com
Phone: +91-33-40251555 / +91-33-40251539
Website: wbcil.com

West Bengal Chemical Industries Limited is a leading API manufacturer with over 60 years of experience in manufacturing APIs for the pharmaceutical, nutritional, food and feed industries.

This release was published on openPR.